InMed Pharmaceuticals Inc. Quarterly Current Ratio in % from Q1 2021 to Q4 2023

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
InMed Pharmaceuticals Inc. quarterly Current Ratio history and growth rate from Q1 2021 to Q4 2023.
  • InMed Pharmaceuticals Inc. Current Ratio for the quarter ending December 31, 2023 was 594 %, a 77.2% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2023 594 +259 +77.2% Dec 31, 2023
Q3 2023 568 +291 +105% Sep 30, 2023
Q2 2023 490 +154 +46.1% Jun 30, 2023
Q1 2023 417 +62.5 +17.6% Mar 31, 2023
Q4 2022 335 -121 -26.5% Dec 31, 2022
Q3 2022 277 -291 -51.3% Sep 30, 2022
Q2 2022 335 -100 -23% Jun 30, 2022
Q1 2022 354 -84.6 -19.3% Mar 31, 2022
Q4 2021 456 Dec 31, 2021
Q3 2021 568 Sep 30, 2021
Q2 2021 435 Jun 30, 2021
Q1 2021 439 Mar 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.